Tag: Regulation

Tax Avoidance or Smart Investing?

What else can derivatives be blamed for?  OTC equity derivatives are now in the spotlight of the IRS for promoting tax avoidance.  The theory is that an equity swap allows the purchaser to collect dividends on the “swapped” stock without paying the taxes associated with actually owning that stock.  I can certainly see the merit […]

The Trade – OTC derivatives reforms to accelerate automation

“The automation that will result from standardisation of OTC derivatives will make it easier to get fair prices, as well as making it simpler to trade and clear them using electronic means,” Kevin McPartland, senior analyst, TABB Group and author of a recent paper titled ‘OTC Derivatives US Regulatory Update’ told theTRADEnews.com. Full Story Here

Compliance Reporter – TABB: Derivatives Rules Coming This Summer

The bill that eventually emerges from the Senate will resemble the House of Representatives’ bill on most major issues, but there are several details that will be hotly debated, McPartland wrote in a recent report. “Exemptions will be a big issue–i.e. which end users will be exempt, even which buyside firms might be exempt,” he […]

Risk.net – Number of OTC derivatives dealers could double after US reforms

At the moment, there are 15 major dealers in OTC derivatives, according to Kevin McPartland, a senior analyst at the TABB Group and author of a new study,OTC Derivatives U.S. Regulatory Update. He believes the number of major dealers could expand to as many as 30 over the next two to five years, as “the […]

SIN – In Icap's World,Offense is the Best Defense Best Defense

Inter-dealer brokers (IDBs) execute about half of all OTC derivatives trades occurring between dealers; the rest, the dealers trade directly between each other. Language in the House bill could give the IDBs the remaining 50 percent of the market in dealer-to-dealer OTC derivatives trading, according to Kevin McPartland, senior analyst at the Tabb Group. McPartland’s […]

TABB Group Pinpoints the OTC Derivatives Regulatory Impact of The Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173)

McPartland analyzes the language of the bill, describes what the OTC derivatives reforms can mean for the marketplace and what lies ahead once the Senate passes their version of the bill by early summer 2010 before a compromise bill is readied for President Obama’s signature. “Depending on the complexion of the bill enacted,” he says, “there […]

UK Response to Derivatives Reform: Protectionism or Pragmatism?

A TABB Group Commentary.  Download free here. Does the UK have a soft spot for OTC derivatives or do they just have a better grasp of reality than the rest of the globe? On 15th December 2009, the UK Financial Services Authority (FSA) and HM Treasury published a joint response to the “EU Consultation Document: […]